Table 5.
Developer country/ organization | CPGs that met IOM criteria | |||||||
---|---|---|---|---|---|---|---|---|
Establishing transparency | Management of conflict of interests | Guideline development group composition | Systematic review intersection | Establishing evidence foundations for and rating strength of recommendations | Articulation of recommendations | External review | Updating | |
Canada [59] | √ | √ | √ | √ | √ | √ | √ | √ |
WHO [60] | √ | √ | √ | √ | √ | √ | √ | √ |
WHO [61] | √ | √ | √ | √ | √ | √ | √ | √ |
China [62] | √ | √ | √ | √ | √ | √ | √ | √ |
Canada [63] | × - | √ | √ | √ | √ | √ | √ | √ |
Australia [64] | √ | √ | √ | √ | √ | √ | √ | √ |
WHO [65] | √ | √ | √ | √ | √ | √ | √ | √ |
These CPGs did not report funding received.